Health & Biotech Equities ETFs are exchange-traded funds that invest in a diversified portfolio of companies that operate in the healthcare and biotechnology sectors. These sectors include companies involved in the research, development, and production of medical products, drugs, and therapies. They can also include companies that provide healthcare services, such as hospitals, insurance companies, and medical device manufacturers.

Health & biotech ETFs can provide investors with exposure to the growth potential of these sectors, which are driven by factors such as demographic changes, technological advancements, and growing demand for healthcare services. However, it's important to note that these ETFs can be more volatile and risky than the overall market, as the success of many companies in this sector is heavily dependent on clinical trial results and regulatory approvals.

Health & Biotech Equities

NYSEArca

SBIO

NasdaqGM

LFSC

iShares U.S. Pharmaceuticals ETF seeks to track U.S. pharmaceutical companies, providing targeted exposure to domestic drug manufacturers and vaccine producers.

Symbol	Name	Sharpe Ratio (1Y)	Sharpe Ratio (5Y)	Sharpe Ratio (10Y)	Risk / Return Rank
BBC	Virtus LifeSci Biotech Clinical Trials ETF	3.82	0.07	0.30	96
SBIO	ALPS Medical Breakthroughs ETF	3.11	0.24	0.36	94
LFSC	F/m Emerald Life Sciences Innovation ETF	3.01	—	—	92
IHE	iShares U.S. Pharmaceuticals ETF	2.95	0.74	0.50	94
XBI	SPDR S&P Biotech ETF	2.87	0.13	0.34	94

Top Health & Biotech Equities ETFs by Sharpe Ratio

Top Health & Biotech Equities ETFs by Sharpe Ratio